Cargando…
P664: REAL-WORLD ANALYSIS OF MUTATION CHARACTERISTICS AND CLINICAL OUTCOMES IN 343 CHRONIC MYELOID LEUKEMIA PATIENTS WITH BCR::ABL KINASE DOMAIN MUTATIONS
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428900/ http://dx.doi.org/10.1097/01.HS9.0000969560.77193.a9 |
_version_ | 1785090581507080192 |
---|---|
author | Hu, Shiwei Wu, Dijiong Feng, Weiying Chen, Lili Cao, Lihong Zhu, Xiaoqiong Yang, Xiudi Zhu, Jingjing Wang, Huafeng Chen, Dan Tong, Hongyan Lu, Ying Qian, Honglan Wang, Yi Jin, Jie Huang, Jian |
author_facet | Hu, Shiwei Wu, Dijiong Feng, Weiying Chen, Lili Cao, Lihong Zhu, Xiaoqiong Yang, Xiudi Zhu, Jingjing Wang, Huafeng Chen, Dan Tong, Hongyan Lu, Ying Qian, Honglan Wang, Yi Jin, Jie Huang, Jian |
author_sort | Hu, Shiwei |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10428900 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-104289002023-08-17 P664: REAL-WORLD ANALYSIS OF MUTATION CHARACTERISTICS AND CLINICAL OUTCOMES IN 343 CHRONIC MYELOID LEUKEMIA PATIENTS WITH BCR::ABL KINASE DOMAIN MUTATIONS Hu, Shiwei Wu, Dijiong Feng, Weiying Chen, Lili Cao, Lihong Zhu, Xiaoqiong Yang, Xiudi Zhu, Jingjing Wang, Huafeng Chen, Dan Tong, Hongyan Lu, Ying Qian, Honglan Wang, Yi Jin, Jie Huang, Jian Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10428900/ http://dx.doi.org/10.1097/01.HS9.0000969560.77193.a9 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
spellingShingle | Posters Hu, Shiwei Wu, Dijiong Feng, Weiying Chen, Lili Cao, Lihong Zhu, Xiaoqiong Yang, Xiudi Zhu, Jingjing Wang, Huafeng Chen, Dan Tong, Hongyan Lu, Ying Qian, Honglan Wang, Yi Jin, Jie Huang, Jian P664: REAL-WORLD ANALYSIS OF MUTATION CHARACTERISTICS AND CLINICAL OUTCOMES IN 343 CHRONIC MYELOID LEUKEMIA PATIENTS WITH BCR::ABL KINASE DOMAIN MUTATIONS |
title | P664: REAL-WORLD ANALYSIS OF MUTATION CHARACTERISTICS AND CLINICAL OUTCOMES IN 343 CHRONIC MYELOID LEUKEMIA PATIENTS WITH BCR::ABL KINASE DOMAIN MUTATIONS |
title_full | P664: REAL-WORLD ANALYSIS OF MUTATION CHARACTERISTICS AND CLINICAL OUTCOMES IN 343 CHRONIC MYELOID LEUKEMIA PATIENTS WITH BCR::ABL KINASE DOMAIN MUTATIONS |
title_fullStr | P664: REAL-WORLD ANALYSIS OF MUTATION CHARACTERISTICS AND CLINICAL OUTCOMES IN 343 CHRONIC MYELOID LEUKEMIA PATIENTS WITH BCR::ABL KINASE DOMAIN MUTATIONS |
title_full_unstemmed | P664: REAL-WORLD ANALYSIS OF MUTATION CHARACTERISTICS AND CLINICAL OUTCOMES IN 343 CHRONIC MYELOID LEUKEMIA PATIENTS WITH BCR::ABL KINASE DOMAIN MUTATIONS |
title_short | P664: REAL-WORLD ANALYSIS OF MUTATION CHARACTERISTICS AND CLINICAL OUTCOMES IN 343 CHRONIC MYELOID LEUKEMIA PATIENTS WITH BCR::ABL KINASE DOMAIN MUTATIONS |
title_sort | p664: real-world analysis of mutation characteristics and clinical outcomes in 343 chronic myeloid leukemia patients with bcr::abl kinase domain mutations |
topic | Posters |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428900/ http://dx.doi.org/10.1097/01.HS9.0000969560.77193.a9 |
work_keys_str_mv | AT hushiwei p664realworldanalysisofmutationcharacteristicsandclinicaloutcomesin343chronicmyeloidleukemiapatientswithbcrablkinasedomainmutations AT wudijiong p664realworldanalysisofmutationcharacteristicsandclinicaloutcomesin343chronicmyeloidleukemiapatientswithbcrablkinasedomainmutations AT fengweiying p664realworldanalysisofmutationcharacteristicsandclinicaloutcomesin343chronicmyeloidleukemiapatientswithbcrablkinasedomainmutations AT chenlili p664realworldanalysisofmutationcharacteristicsandclinicaloutcomesin343chronicmyeloidleukemiapatientswithbcrablkinasedomainmutations AT caolihong p664realworldanalysisofmutationcharacteristicsandclinicaloutcomesin343chronicmyeloidleukemiapatientswithbcrablkinasedomainmutations AT zhuxiaoqiong p664realworldanalysisofmutationcharacteristicsandclinicaloutcomesin343chronicmyeloidleukemiapatientswithbcrablkinasedomainmutations AT yangxiudi p664realworldanalysisofmutationcharacteristicsandclinicaloutcomesin343chronicmyeloidleukemiapatientswithbcrablkinasedomainmutations AT zhujingjing p664realworldanalysisofmutationcharacteristicsandclinicaloutcomesin343chronicmyeloidleukemiapatientswithbcrablkinasedomainmutations AT wanghuafeng p664realworldanalysisofmutationcharacteristicsandclinicaloutcomesin343chronicmyeloidleukemiapatientswithbcrablkinasedomainmutations AT chendan p664realworldanalysisofmutationcharacteristicsandclinicaloutcomesin343chronicmyeloidleukemiapatientswithbcrablkinasedomainmutations AT tonghongyan p664realworldanalysisofmutationcharacteristicsandclinicaloutcomesin343chronicmyeloidleukemiapatientswithbcrablkinasedomainmutations AT luying p664realworldanalysisofmutationcharacteristicsandclinicaloutcomesin343chronicmyeloidleukemiapatientswithbcrablkinasedomainmutations AT qianhonglan p664realworldanalysisofmutationcharacteristicsandclinicaloutcomesin343chronicmyeloidleukemiapatientswithbcrablkinasedomainmutations AT wangyi p664realworldanalysisofmutationcharacteristicsandclinicaloutcomesin343chronicmyeloidleukemiapatientswithbcrablkinasedomainmutations AT jinjie p664realworldanalysisofmutationcharacteristicsandclinicaloutcomesin343chronicmyeloidleukemiapatientswithbcrablkinasedomainmutations AT huangjian p664realworldanalysisofmutationcharacteristicsandclinicaloutcomesin343chronicmyeloidleukemiapatientswithbcrablkinasedomainmutations |